Trademark: 90319249
Word

Status
Pending
Status Code
616
Status Date
Monday, March 11, 2024
Serial Number
90319249
Mark Type
2000
Filing Date
Friday, November 13, 2020
Published for Opposition
Tuesday, June 14, 2022

Trademark Owner History
Source Donor Inc. - Owner At Publication

Classifications
40 Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma for transplant purposes, medicinal purposes, and for use by others in scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals; Treatment of materials, namely, treatment of blood and blood plasma for transplant purposes, medicinal purposes, and for use by others in scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals
9 Downloadable mobile software application for use in scheduling appointments with blood plasma donation center for the collection of blood plasma, for tracking the associated compensation and incentive rewards associated with those appointments, for managing memberships associated with the blood plasma donation centers and those appointments, and for receiving news from blood plasma donation centers in the field of blood plasma donation and the use of blood plasma
39 Transport, distribution in the nature of delivery, and storage of blood plasma
35 Promoting the donation of blood and volunteer services and financial resources in the field of blood and human blood plasma donations by means of arranging and conducting incentive reward programs and compensation programs
44 Collection of human blood plasma; medical testing of human blood plasma for diagnostic or treatment purposes; blood bank services; medical screening of human blood plasma for diagnostic or treatment purposes; Blood plasma donation center services; Medical services, particularly the medical services of a blood donation center; Blood component collection services
42 Medical laboratory services, namely, testing and screening of human blood plasma for scientific research and development purposes; Medical laboratory services regarding human blood plasma; scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals by means of processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals by means of treatment of blood and blood plasma
The mark consists of a stylized depiction of a parachute comprised of 3 segments.

Trademark Events
Mar 11, 2024
Notice Of Revival - E-Mailed
Mar 11, 2024
Sou Extension Received With Teas Petition
Mar 11, 2024
Notice Of Revival - E-Mailed
Mar 11, 2024
Petition To Revive-Granted
Mar 11, 2024
Teas Petition To Revive Received
Mar 11, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 11, 2024
Abandonment - No Use Statement Filed
Aug 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2023
Sou Extension 2 Granted
Aug 9, 2023
Sou Extension 2 Filed
Aug 9, 2023
Sou Teas Extension Received
Feb 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 9, 2023
Sou Extension 1 Granted
Feb 9, 2023
Sou Extension 1 Filed
Feb 9, 2023
Sou Teas Extension Received
Aug 9, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2022
Published For Opposition
May 25, 2022
Notification Of Notice Of Publication E-Mailed
May 9, 2022
Approved For Pub - Principal Register
May 9, 2022
Examiner's Amendment Entered
May 9, 2022
Notification Of Examiners Amendment E-Mailed
May 9, 2022
Examiners Amendment E-Mailed
May 9, 2022
Examiners Amendment -Written
Nov 8, 2021
Notification Of Final Refusal Emailed
Nov 8, 2021
Final Refusal E-Mailed
Nov 8, 2021
Final Refusal Written
Nov 2, 2021
Teas/Email Correspondence Entered
Nov 1, 2021
Correspondence Received In Law Office
Nov 1, 2021
Teas Response To Office Action Received
Apr 30, 2021
Notification Of Non-Final Action E-Mailed
Apr 30, 2021
Non-Final Action E-Mailed
Apr 30, 2021
Non-Final Action Written
Apr 22, 2021
Assigned To Examiner
Jan 15, 2021
Notice Of Design Search Code E-Mailed
Jan 14, 2021
New Application Office Supplied Data Entered
Nov 17, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24